11 – 20 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Peripheral Artery Disease In Patients With Acute Myocardial Infarction
2019) The American College of Cardiology 68th Annual Scientific Sessions In Journal of the American College of Cardiology 73(9 Suppl 1). p.23-23(
- Contribution to journal › Published meeting abstract
-
Mark
The effect of schizophrenia on major adverse cardiac events, length of hospital stay, and prevalence of somatic comorbidities following acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : A Prespecified Analysis From the VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk for cardiac events
(
- Contribution to journal › Article
- 2018
-
Mark
Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction.
(
- Contribution to journal › Article
-
Mark
Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve : A Substudy From the iFR-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Coronary angiographic findings and outcomes in patients with sudden cardiac arrest without ST-elevation myocardial infarction : A SWEDEHEART study
(
- Contribution to journal › Article
-
Mark
Increased All-Cause Mortality in Patients With Schizophrenia Following Acute Coronary Syndrome
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Intravascular Ultrasound Guidance is Associated with Better Outcome in Patients Undergoing Unprotected Left Main Coronary Artery Stenting Compared with Angiography Guidance Alone
(
- Contribution to journal › Article
-
Mark
Cangrelor in combination with ticagrelor provides consistent and potent P2Y12-inhibition during and after primary percutaneous coronary intervention in real-world patients with ST-segment-elevation myocardial infarction
(
- Contribution to journal › Article